Manager-Analytical Development

As a member of the Jubilant Pharma Limited team, you will be part of a global integrated pharmaceutical company that offers a diverse range of products and services to customers worldwide. Our business is structured into two key segments: Specialty Pharmaceuticals and Generics & APIs. In the Specialty Pharmaceuticals segment, we specialize in Radiopharmaceuticals, Contract Manufacturing of Sterile Injectable, Non-sterile & Allergy Therapy Products. The Generics & APIs segment focuses on Solid Dosage Formulations & Active Pharmaceutical Ingredients. Jubilant Generics (JGL), our wholly-owned subsidiary, has Research & Development units located in Noida and Mysore, India. JGL operates manufacturing facilities in Mysore, Karnataka, and Roorkee, Uttarakhand, dedicated to APIs and Dosage manufacturing. The Mysore manufacturing site, spread over 69 acres and USFDA approved, produces APIs for global distribution, focusing on Lifestyle driven Therapeutic Areas such as CVS and CNS. The Roorkee facility is state-of-the-art, approved by multiple regulatory bodies catering to B2B markets in EU, Canada, and emerging markets. Our backward-integrated manufacturing units are supported by a team of 500 research and development professionals based in Noida and Mysore. The R&D team focuses on developing new products in API, Solid Dosage Formulations, Sterile Injectable products, Semi-Solids like Ointments, Creams, and Liquids. We conduct all BA/BE studies in-house at an 80 Bed facility with global regulatory accreditations. JGL's Regulatory Affairs & IPR professionals manage a unique portfolio of patents and product filings for regulatory and non-regulatory markets. Jubilant Pharma has witnessed consistent revenue growth, with revenue reaching INR 53,240 Million in the Financial Year 2018-19, compared to INR 39,950 Million in the Financial Year 2017-18. For more information about our organization, please visit www.jubilantpharma.com.,